Guido Ceci

975 total citations
34 papers, 756 citations indexed

About

Guido Ceci is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guido Ceci has authored 34 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guido Ceci's work include Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (7 papers). Guido Ceci is often cited by papers focused on Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (7 papers). Guido Ceci collaborates with scholars based in Italy, United States and Switzerland. Guido Ceci's co-authors include Giorgio Cocconi, C. Boni, Giancarlo Bisagni, Renata Lottici, M. Bacchi, Franco Buzzi, Mariangela Bella, Maurizio Tonato, R Canaletti and E. Corgna and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Guido Ceci

34 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Ceci Italy	15	455	215	199	110	102	34	756
G Delides Greece	18	254 0.6×	279 1.3×	298 1.5×	79 0.7×	107 1.0×	51	855
Paola Marroni Italy	14	259 0.6×	174 0.8×	284 1.4×	98 0.9×	89 0.9×	40	679
M. Paganuzzi Italy	16	331 0.7×	257 1.2×	518 2.6×	111 1.0×	99 1.0×	38	992
Cherie Perez United States	9	314 0.7×	419 1.9×	198 1.0×	89 0.8×	149 1.5×	16	955
Hoo G. Chun United States	15	440 1.0×	304 1.4×	210 1.1×	70 0.6×	59 0.6×	31	821
Darlene Gibbon United States	15	325 0.7×	375 1.7×	115 0.6×	126 1.1×	109 1.1×	38	834
Yoko Nakanishi Japan	14	282 0.6×	226 1.1×	208 1.0×	116 1.1×	165 1.6×	58	714
Pamela Lockbaum United States	9	763 1.7×	167 0.8×	222 1.1×	72 0.7×	63 0.6×	13	983
Andrew Sherrod United States	13	529 1.2×	331 1.5×	257 1.3×	47 0.4×	103 1.0×	21	1.0k
D. Fırat Türkiye	14	192 0.4×	115 0.5×	130 0.7×	144 1.3×	73 0.7×	46	680

Countries citing papers authored by Guido Ceci

Since Specialization

Citations

This map shows the geographic impact of Guido Ceci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Ceci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Ceci more than expected).

Fields of papers citing papers by Guido Ceci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Ceci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Ceci. The network helps show where Guido Ceci may publish in the future.

Co-authorship network of co-authors of Guido Ceci

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Ceci. A scholar is included among the top collaborators of Guido Ceci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Ceci. Guido Ceci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Musolino, Antonino, Maria Michiara, Vittorio Franciosi, et al.. (2005). Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO‐P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non‐Hodgkin lymphoma. Cancer. 103(10). 2109–2117. 8 indexed citations

Cocconi, Giorgio, Vittorio Franciosi, Anna Dodero, et al.. (2003). P-CHOP: Cisplatin (P) Added to the Standard CHOP Regimen as First-Line Treatment for Aggressive Non-Hodgkin Lymphoma. American Journal of Clinical Oncology. 26(6). 535–542. 1 indexed citations

Cocconi, Giorgio, C. Boni, Giancarlo Bisagni, et al.. (2002). Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma. Cancer. 95(2). 228–235. 6 indexed citations

Cocconi, Giorgio, Mariangela Bella, Renata Lottici, et al.. (1999). Mature Results of a Prospective Randomized Trial Comparing a Three-Weekly with an Accelerated Weekly Schedule of Cisplatin in Advanced Ovarian Carcinoma. American Journal of Clinical Oncology. 22(6). 559–559. 18 indexed citations

Cocconi, Giorgio, Giancarlo Bisagni, Guido Ceci, et al.. (1999). Three new active cisplatin‐containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial. Breast Cancer Research and Treatment. 56(2). 123–130. 11 indexed citations

Boni, C., Luisa Savoldi, Giancarlo Bisagni, et al.. (1998). Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC). European Journal of Cancer. 34(12). 1974–1976. 2 indexed citations

Bozzetti, Cecilia, Rita Nizzoli, Roberta Camisa, et al.. (1997). Comparison between ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma. Cancer. 81(5). 287–292. 15 indexed citations

Pipan, Corrado, et al.. (1996). Vertical transmission of hepatitis C virus in low-risk pregnant women. European Journal of Clinical Microbiology & Infectious Diseases. 15(2). 116–120. 34 indexed citations

Crinò, Lucio, M. Clerici, F. Figoli, et al.. (1995). Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Annals of Oncology. 6(4). 347–353. 70 indexed citations

10.

Bisagni, Giancarlo, Giorgio Cocconi, Benedetto Di Blasio, et al.. (1994). M-VAC combination in locally advanced, locally recurrent or metastatic breast carcinoma. A phase II study. Annals of Oncology. 5(1). 93–94. 6 indexed citations

11.

Crinò, Lucio, M. Clerici, F. Figoli, et al.. (1993). Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC). European Journal of Cancer. 29. S159–S159. 11 indexed citations

12.

Cocconi, Giorgio, Giancarlo Bisagni, Guido Ceci, et al.. (1992). Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.. Journal of Clinical Oncology. 10(6). 984–989. 15 indexed citations

13.

Cocconi, Giorgio, Mariangela Bella, F. Calabresi, et al.. (1992). Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen. New England Journal of Medicine. 327(8). 516–523. 180 indexed citations

14.

Cocconi, Giorgio, Giancarlo Bisagni, M. Bacchi, et al.. (1991). Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.. Journal of Clinical Oncology. 9(4). 664–669. 53 indexed citations

15.

Passalacqua, Rodolfo, et al.. (1991). Cisplatin and etoposide in advanced colorectal carcinoma. Annals of Oncology. 2(9). 687–688. 17 indexed citations

16.

Cocconi, Giorgio, Giancarlo Bisagni, M. Bacchi, et al.. (1990). A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Annals of Oncology. 1(1). 36–44. 18 indexed citations

17.

Boni, C., et al.. (1989). Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial. Cancer. 63(4). 638–642. 42 indexed citations

18.

Ceci, Guido, Vittorio Franciosi, Rodolfo Passalacqua, et al.. (1988). The value of bone marrow biopsy in breast cancer at the time of first relapse.A prospective study. Cancer. 61(5). 1041–1045. 7 indexed citations

19.

Ceci, Guido, Vittorio Franciosi, Rita Nizzoli, et al.. (1988). The value of bone marrow biopsy in breast cancer at time of diagnosis.A prospective study. Cancer. 61(1). 96–98. 14 indexed citations

20.

Ceci, Guido, et al.. (1988). Fatal hepatic vascular toxicity of DTIC.Is it really a rare event?. Cancer. 61(10). 1988–1991. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact